HealthEquity, Inc. (NASDAQ:HQY) Receives $113.09 Average Target Price from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been given an average recommendation of "Buy" by the eleven ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $118.09.

Several research firms recently commented on HQY. The Goldman Sachs Group boosted their target price on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. KeyCorp lowered their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Royal Bank of Canada boosted their target price on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th.

HealthEquity Trading Down 0.3%

Shares of HQY stock traded down $0.36 on Wednesday, hitting $112.70. The stock had a trading volume of 1,948,931 shares, compared to its average volume of 824,265. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a market capitalization of $9.75 billion, a P/E ratio of 103.39, a P/E/G ratio of 1.60 and a beta of 0.45. HealthEquity has a 1 year low of $65.01 and a 1 year high of $116.69. The company's 50 day moving average price is $90.51 and its 200-day moving average price is $97.67.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the business earned $0.80 EPS. Analysts anticipate that HealthEquity will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On HealthEquity

Large investors have recently modified their holdings of the business. Ameritas Investment Partners Inc. grew its holdings in shares of HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Louisiana State Employees Retirement System boosted its holdings in shares of HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its holdings in shares of HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after purchasing an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System boosted its holdings in shares of HealthEquity by 0.5% during the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.